Aspire Biopharma Holdings, Inc. (ASBP): auditor change — Aspire Biopharma dismisses auditor Bush, appoints Turner Stone; gets $1M funding tranche

Aspire Biopharma Holdings, Inc.

Dismissed Bush & Associates CPA as independent auditor effective Sept 22, 2025; 2024 audit included going concern explanatory paragraph.
Appointed Turner Stone & Co. as new independent auditor for FY 2025, effective Sept 22, 2025.
No disagreements with Bush; material weaknesses in internal control over financial reporting were disclosed.
Received $1M second tranche funding under Securities Purchase Agreement for notes with aggregate principal $9.6875M.

item 3.02 item 4.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Aspire Biopharma Holdings, Inc. dismissed Bush & Associates CPA as its auditor.

Action: dismissal
Auditor: Bush & Associates CPA
Successor: Turner Stone & Co

Exact text from the filing

.01 Changes in Registrant’s Certifying Accountant (a) Termination of Previous Independent Registered Accounting Firm On September 22, 2025 Bush & Associates CPA ( “Bush” ) was dismissed by the Audit Committee of the Board of Directors of Aspire Biopharma Holdings, Inc.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Aspire Biopharma Holdings, Inc. engaged Turner Stone & Co as its auditor.

Action: engagement
Auditor: Turner Stone & Co

Exact text from the filing

(b) Appointment of New Independent Registered Public Accounting Firm On September 22, 2025, the Company’s Audit Committee approved the engagement of Turner Stone & Co ( “Turner” ) as the Company’s new independent registered public accounting firm for the fiscal year ending December 31, 2025, effective immediately.

View on SEC.gov

19 auditor changes filed in the last 30 days. Browse all auditor changes →

Aspire Biopharma Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-015773

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.